Dane Hamilton

Genomics Shares Slide as Lehman Calls Sector Overvalued

By Dane Hamilton

The brokerage house points out that these companies are years from having actual profit-making products.

04:30PM 01/31/01

Pozen Plunges on Migraine Drug's Setback

By Dane Hamilton

Interactivity concerns prompt the FDA to push for more tests, analysts say.

05:08PM 01/26/01

Quiet on Claritin Replacement Disquiets Schering-Plough Investors

By Dane Hamilton

The FDA preliminarily backs desloratadine, but analysts wonder if the drug is on the slow track.

03:25PM 01/26/01

American Home in Fat City Even as Charge Swells

By Dane Hamilton

Investors bid up the stock after the company adds once more to its diet-drug litigation reserve.

01:56PM 01/25/01

Merck Profits Jump 14% as Drug Juggernaut Rolls

By Dane Hamilton

Sales of Zocor and Vioxx lead the way.

10:52AM 01/23/01

Biotech Stocks Rally as Amgen Prevails in Patent Case

By Dane Hamilton

A ruling against Transkaryotic ignites a 6% surge in biotech stocks.

12:42PM 01/22/01

Genentech Slides as Drug Setbacks Trim Optimism

By Dane Hamilton

The biotech has long delivered strong results, but recent developments have some observers concerned.

04:28PM 01/19/01

Genentech's Numbers Meet Expectations

By Dane Hamilton

The biotech firm cites strong sales of its leading cancer drugs.

05:44PM 01/18/01

Biogen Beats Estimates as Avonex Sales Rise

By Dane Hamilton

Sales of the biotech company's main product are 'reinvigorated.'

05:14PM 01/17/01

Shorts Salivate as Alexion Prepares Drug Data

By Dane Hamilton

Some investors think the company's enzyme numbers won't stand up to doctors' scrutiny.

09:59AM 01/17/01